Re: To our scientist
|
8
|
Resverlogix Corp.
|
Dec 07, 2020 07:46PM
|
Re: We need safe and effective Covid therapies
|
7
|
Resverlogix Corp.
|
Sep 29, 2021 10:03AM
|
Seeking Alpha slide show
|
6
|
Resverlogix Corp.
|
Mar 22, 2017 09:28PM
|
Re: Any catalysts in Q1 to awaken the masses?
|
5
|
Resverlogix Corp.
|
Jan 20, 2016 02:23PM
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
4
|
Resverlogix Corp.
|
Jan 30, 2019 05:09PM
|
Re: Hold or fold?
|
3
|
Resverlogix Corp.
|
Dec 17, 2020 11:34AM
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 04:28PM
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 08:53PM
|
Take Home Points: not ready for use in patients
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 03:53PM
|
Re: AGM Notice
|
2
|
Resverlogix Corp.
|
Nov 03, 2016 12:08PM
|
Re: Warrants versus Shares...
|
2
|
Resverlogix Corp.
|
Jun 26, 2017 02:28PM
|
Volume
|
2
|
Resverlogix Corp.
|
Nov 30, 2020 12:55PM
|
Epigenetic Stem Cell Article NY Times
|
2
|
Resverlogix Corp.
|
Mar 29, 2020 10:11PM
|
Epigenitics
|
2
|
Resverlogix Corp.
|
Dec 15, 2016 08:40PM
|
Re: RRSP to TFSA
|
1
|
Zenith Epigenetics
|
Mar 07, 2019 11:17AM
|
Difference between DSMB #7 and DSMB #8
|
1
|
Resverlogix Corp.
|
Dec 19, 2018 02:40PM
|
Re: New Insider filing dated Feb 12 - Change in the nature of ownership
|
1
|
Resverlogix Corp.
|
Feb 16, 2020 04:42PM
|